Search Results 1091-1100 of 10551 for total t4

  1. A Study to Evaluate Pulmonary Vascular Complications of Liver Disease 3 (PVCLD3) - Mayo Clinic

    The purpose of this study is toexamine whether increased sphingosine 1 phosphate : ceramide ratio and circulating bile acids are associated with HPS in patients ...

  2. Gastroenterology and Hepatology - Clinical trials

    The primary study hypothesis is that pembrolizumab will prolong progression-free survival (PFS) or overall survival (OS) compared to current SOC chemotherapy.

  3. Gastroenterology and Hepatology - Clinical trials

    The primary study hypothesis is that pembrolizumab will prolong progression-free survival (PFS) or overall survival (OS) compared to current SOC chemotherapy.

  4. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Total bilirubin < 1.5 x upper limit of normal (ULN) (or < 3 x ULN for subjects with Gilbert's syndrome); Creatinine clearance ≥ 50 mL/min on the basis of ...

  5. A Study Of Follow Up On Patients Who Participated In The SIMPLE Study - Mayo Clinic

    Patients who did not complete surveys at baseline and 12 months post-transplant as a part of the SIMPLE study. Note: Other protocol defined Inclusion ...

  6. Clinical trials - Oncology (Medical)

    The overall goals of this study are to evaluate similarities and differences of the known genetic and non-genetic epidemiological factors associated with ...

  7. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    About this study. To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic ...

  8. Clinical trials - Oncology (Medical)

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...

  9. Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML - Mayo Clinic

    ... Total Body Irradiation (Cy/TBI) Cyclophosphamide (120 mg/kg) TBI (1200-1420 cGy). • Recovery of counts by day 42 and able to start midostaurin by day 60 post ...

  10. Clinical trials - Oncology (Medical)

    ... complete resection. Patient Adherence and Symptoms During Post-operative Fluid Restriction Protocol After Transsphenoidal Surgery. Jacksonville, Fla. The ...